查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378767

脉络膜新生血管市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球脉络膜新生血管市场规模达到60亿美元。展望未来， IMARC Group预计到2028年市场规模将达到95亿美元，2022-2028年复合年增长率（CAGR）为8.0%。

脉络膜新生血管（CNV）是指在眼睛脉络膜层产生新血管，影响布鲁赫膜和视网膜色素上皮（RPE）。其症状包括脂质渗出、视网膜下血液和液体、中央视力扭曲、波纹和黑点。目前，结合萤光素血管摄影（FA）、吲哚菁绿（ICG）血管摄影和光学相干断层扫描（OCT）扫描等方法来诊断CNV。根据结果，医生会开出抗血管内皮生长因子（VEGF）药物、热雷射治疗和光动力治疗（PDT），以防止血管生长。

由于老年性黄斑部病变（ARMD）、眼组织胞浆菌病、病理性近视、血管样条纹、脉络膜撕裂以及脉络膜和视网膜发炎性疾病的盛行率不断上升，该市场正在经历增长。此外，越来越多的老年人口更容易受到严重健康状况的影响，这是推动市场成长的另一个关键因素。此外，联合药物的日益普及，以及长效抗 VEGF 药物的推出，正在推动全球对 CNV 治疗的需求。其他因素，例如改善医疗基础设施和增加研发 (R&D) 活动投资，也促进了市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球脉络膜新生血管市场表现如何，未来几年将如何表现？
  • COVID-19 对全球脉络膜新生血管市场有何影响？
  • 主要区域市场有哪些？
  • 依产品类型分類的市场是怎么样的？
  • 根据诊断类型，市场的划分是怎么样的？
  • 根据治疗类型的市场划分是怎样的？
  • 基于应用程式的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球脉络膜新生血管市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球脉络膜新生血管市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 静脉
    • 市场走向
    • 市场预测
  • 玻璃体内
    • 市场走向
    • 市场预测

第 7 章：按诊断类型分類的市场

  • 萤光血管摄影 (FA)
    • 市场走向
    • 市场预测
  • 吲哚菁绿 (ICG) 血管摄影
    • 市场走向
    • 市场预测
  • 光谱域光学相干断层扫描 (OCT)
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按治疗类型分類的市场区隔

  • 血管新生抑制剂注射液
    • 市场走向
    • 市场预测
  • 光动力疗法
    • 市场走向
    • 市场预测
  • 雷射光凝
    • 市场走向
    • 市场预测
  • 低剂量放射治疗
    • 市场走向
    • 市场预测
  • 手术
    • 市场走向
    • 市场预测

第 9 章：按应用分類的市场区隔

  • 极度近视
    • 市场走向
    • 市场预测
  • 恶性近视变性
    • 市场走向
    • 市场预测
  • 与年龄相关的发展
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bausch Health Companies Inc.
    • Bayer AG
    • Gilead Sciences, Inc.
    • F. Hoffmann-La Roche AG
    • MaaT Pharma
    • Novartis AG
    • Pfizer Inc.
    • Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
    • Regeneron Pharmaceuticals Inc.
    • Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
Product Code: SR112023A2561

Abstract

The global choroidal neovascularization market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.0% during 2022-2028.

Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.

Breakup by Product Type:

Intravenous

Intravitreal

Breakup by Type of Diagnosis:

Fluorescein Angiography (FA)

Indocyanine Green (ICG) Angiography

Spectral Domain Optical Coherence Tomography (OCT)

Others

Breakup by Treatment Type:

Angiogenesis Inhibitors Injection

Photodynamic Therapy

Laser photocoagulation

Low-dose Radiation Therapy

Surgery

Breakup by Application:

Extreme Myopia

Malignant Myopic Degeneration

Age-Related Developments

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).

Key Questions Answered in This Report:

  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Choroidal Neovascularization Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Intravenous
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravitreal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Diagnosis

  • 7.1 Fluorescein Angiography (FA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Indocyanine Green (ICG) Angiography
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spectral Domain Optical Coherence Tomography (OCT)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Angiogenesis Inhibitors Injection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Photodynamic Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Laser Photocoagulation
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Low-dose Radiation Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Extreme Myopia
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Malignant Myopic Degeneration
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Age-Related Developments
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Gilead Sciences, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 MaaT Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Regeneron Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
  • Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2022
  • Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2022
  • Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
  • Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
  • Figure 87: Global: Choroidal Neovascularization Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2023-2028
  • Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Choroidal Neovascularization Market Structure
  • Table 8: Global: Choroidal Neovascularization Market: Key Players